Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Recruiting

Phase 1

IDE397Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Sponsor:

IDEAYA Biosciences

Code:

NCT04794699

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE397

Docetaxel

Paclitaxel

Sacituzumab govitecan

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-25. This information was provided to ClinicalTrials.gov by IDEAYA Biosciences on 2024-11-18.